Trials / Unknown
UnknownNCT05056025
Study to Evaluate the Response to Supplementation With Postbiotics in Patients With Macular Degeneration.
A PILOT STUDY TO EVALUATE THE PROGRESSION OF THE DISEASE AND RESPONSE TO SUPPLEMENTATION WITH POSTBIOTICS IGEN-0222 IN PATIENTS WITH MACULAR DEGENERATION
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Institut de la Macula y la Retina · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
A pilot study to establish the efficacy and safety of supplementation with postbiotics in patients with macular degeneration.
Conditions
- AMD
- Soft Drusen
- Reticular Pseudodrusen
- Drusen Stage Macular Degeneration
- Drusen (Degenerative) of Macula, Bilateral
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Postbotics and Vitamins | 2 capsule 3 times a day, before meals |
| DIETARY_SUPPLEMENT | Vitamins | 2 capsule 3 times a day, before meals |
Timeline
- Start date
- 2020-12-02
- Primary completion
- 2023-01-01
- Completion
- 2024-01-01
- First posted
- 2021-09-24
- Last updated
- 2021-09-24
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05056025. Inclusion in this directory is not an endorsement.